The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock
Primary Purpose
Septic Shock
Status
Active
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Methylene Blue
Sponsored by
About this trial
This is an interventional treatment trial for Septic Shock focused on measuring septic shock, methylene blue, vasopressor, refractory shock
Eligibility Criteria
Inclusion Criteria:
- Septic shock, receive 0.5 ug/kg/min NA to maintain blood pressure for more than 2 hours after fluid resuscitation.
Exclusion Criteria:
- Pregnant women
- Without internal jugular vein or subclavian vein catheterization
- Child-Pugh grade C with liver cirrhosis
- Severe chronic obstructive pulmonary disease (severe acidosis caused by type II respiratory failure, PaCO2 ≥60mmHg and PH<7.2 )
- End-stage of malignant tumors
- Glucose-6-phosphate dehydrogenase (G6PD enzyme) deficiency
- Positive end-respiratory pressure (PEEP) >10mmHg, the oxygenation index <150mmHg under mechanical ventilation
- Definitive pulmonary hypertension or chronic pulmonary heart disease.
- Oral use of 5-hydroxytryptamine in recent 3 months
Sites / Locations
- Xiangya Hospital, Central South University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
MB group
control group
Arm Description
This group will be given 2mg/kg methylene blue infusion within 20 minutes, 2 hours later followed by 0.5mg/kg/h for 4 hours.
This group will be given conventional vasopressors, except methylene blue, based on the attending doctor's decision.
Outcomes
Primary Outcome Measures
SOFA score
72 hours after inclusion
Secondary Outcome Measures
duration of shock
the duration between diagnosis and relief of septic shock, the latter is defined by stable blood pressure without any vasopressor for 2 hours
Full Information
NCT ID
NCT04970602
First Posted
June 29, 2021
Last Updated
July 20, 2021
Sponsor
Xiangya Hospital of Central South University
1. Study Identification
Unique Protocol Identification Number
NCT04970602
Brief Title
The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock
Official Title
The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock
Study Type
Interventional
2. Study Status
Record Verification Date
June 2021
Overall Recruitment Status
Active, not recruiting
Study Start Date
June 20, 2021 (Actual)
Primary Completion Date
June 30, 2023 (Anticipated)
Study Completion Date
January 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Xiangya Hospital of Central South University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study will include patients requiring high dose of norepinephrine (NA) to maintain blood pressure after fluid resuscitation. The patients will be randomized into two groups, the study protocol is early combined application of methylene blue. The primary outcome is Sequential Organ Failure Assessment (SOFA) score 72 hours after admission. Second outcome includes duration of shock, length of intensive care unit (ICU) hospitalization and so on. To explore the underlying mechanism, the changes of sublingual microcirculation before and after vasopressor combination will be collected, also is the global longitudinal strain of left ventricle.
Detailed Description
Background: Decreased vascular tone is one of the main mechanisms leading to septic shock. The guidelines recommend NA as the first-line vasopressor. The benefits of early combination with other vasopressors are not yet known.
Methods:
Patients: Septic shock patients in need of high dose of NA (≥0.5ug/kg.min maintaining more than 2 hours) to maintain blood pressure after fluid resuscitation.
Intervention: The patients will be randomized into two groups. The study group will receive 2mg/kg methylene blue infusion with 15 minutes, 2 hours laters followed by 0.5mg/kg/h for 4 hours. The control group received conventional treatments, the attending physicians decide the protocol of vasopressors. The data including patients' characters, duration of shock and hospitalization, duration of mechanical ventilation, cumulative dose of vasopressors will be collected. Before and 6h after meeting the inclusion standard, sublingual microcirculation and automated function imaging of myocardium will be performed.
Outcome: The primary outcome is SOFA score 72 hours after admission. Second outcome includes duration of shock, length of ICU hospitalization and so on. the changes of sublingual microcirculation will be collected, also is the global longitudinal strain of left ventricle.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Shock
Keywords
septic shock, methylene blue, vasopressor, refractory shock
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
106 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
MB group
Arm Type
Experimental
Arm Description
This group will be given 2mg/kg methylene blue infusion within 20 minutes, 2 hours later followed by 0.5mg/kg/h for 4 hours.
Arm Title
control group
Arm Type
No Intervention
Arm Description
This group will be given conventional vasopressors, except methylene blue, based on the attending doctor's decision.
Intervention Type
Drug
Intervention Name(s)
Methylene Blue
Intervention Description
Once the patient meets inclusion criterial, the interventional group will receive 2mg/kg methylene blue infusion within 20min, followed by 0.5mg/kg/h for 4 hours.
Primary Outcome Measure Information:
Title
SOFA score
Description
72 hours after inclusion
Time Frame
72 hours
Secondary Outcome Measure Information:
Title
duration of shock
Description
the duration between diagnosis and relief of septic shock, the latter is defined by stable blood pressure without any vasopressor for 2 hours
Time Frame
2 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Septic shock, receive 0.5 ug/kg/min NA to maintain blood pressure for more than 2 hours after fluid resuscitation.
Exclusion Criteria:
Pregnant women
Without internal jugular vein or subclavian vein catheterization
Child-Pugh grade C with liver cirrhosis
Severe chronic obstructive pulmonary disease (severe acidosis caused by type II respiratory failure, PaCO2 ≥60mmHg and PH<7.2 )
End-stage of malignant tumors
Glucose-6-phosphate dehydrogenase (G6PD enzyme) deficiency
Positive end-respiratory pressure (PEEP) >10mmHg, the oxygenation index <150mmHg under mechanical ventilation
Definitive pulmonary hypertension or chronic pulmonary heart disease.
Oral use of 5-hydroxytryptamine in recent 3 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xiangya Hospital, Central South University
Organizational Affiliation
Department of Critical Care Medicine, Xiangya Hospital, Central South University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Xiangya Hospital, Central South University
City
Changsha
State/Province
Hunan
ZIP/Postal Code
410008
Country
China
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The study protocol, objective data could be shared when required.
IPD Sharing Time Frame
Within 1 year after completion of the study.
IPD Sharing Access Criteria
Just for academic requirement.
Learn more about this trial
The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock
We'll reach out to this number within 24 hrs